Diana M. Metes

Diana M. Metes


Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 April 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
LBLisa B Boyette
Lisa B Boyette
CMCamila Macedo
Camila Macedo
KHKevin Hadi
Kevin Hadi
BEBeth D Elinoff
Beth D Elinoff
JWJohn T Walters
John T Walters
DMDiana M. Metes
Diana M. Metes
Human monocytes have been grouped into classical (CD14++CD16−), non-classical (CD14dimCD16++), and intermediate (CD14++CD16+) subsets. Documentation of normal function and variation in this complement of subtypes, particularly their differentiation potential to dendritic cells (DC) or macrophages, remains incomplete. We therefore phenotyped monocytes from peripheral blood of healthy subjects and performed functional studies on high-speed sorted subsets. Subset frequencies were found to be tightly controlled over time and across individuals. Subsets were distinct in their secretion of TNFα, IL-6, and IL-1β in response to TLR agonists, with classical monocytes being the most producers and non-classical monocytes the least. Monocytes, particularly those of the non-classical subtype, secreted interferon-α (IFN-α) in response to intracellular TLR3 stimulation. After incubation with IL-4 and GM-CSF, classical monocytes acquired monocyte-derived DC (mo-DC) markers and morphology and stimulated allogeneic T cell proliferation in MLR; intermediate and non-classical monocytes did not. After incubation with IL-3 and Flt3 ligand, no subset differentiated to plasmacytoid DC. After incubation with GM-CSF (M1 induction) or macrophage colony-stimulating factor (M-CSF) (M2 induction), all subsets acquired macrophage morphology, secreted macrophage-associated cytokines, and displayed enhanced phagocytosis. From these studies we conclude that classical monocytes are the principal source of mo-DCs, but all subsets can differentiate to macrophages. We also found that monocytes, in particular the non-classical subset, represent an alternate source of type I IFN secretion in response to virus-associated TLR agonists.

1 September 2009 in American Journal of Transplantation
Verified
Journal Article
Open access
PDF file
CMC. Macedo
C. Macedo
EOE. A. Orkis
E. A. Orkis
IPI. Popescu
I. Popescu
BEB. D. Elinoff
B. D. Elinoff
AZA. Zeevi
A. Zeevi
DMDiana M. Metes
Diana M. Metes
T-cell alloimmunity plays a dominant role in allograft rejection. The precise contribution of naïve and memory T cells to this response however remains unclear. To address this question, we established an ex vivo flow-cytometric assay that simultaneously measures proliferation, precursor frequency and effector molecule (IFNgamma, granzyme B/perforin) production of alloreactive T cells. By applying this assay to peripheral blood mononuclear cells from healthy volunteers, we demonstrate that the CD4+ and CD8+ populations mount similar proliferative responses and contain comparable frequencies of alloreactive precursors. Effector molecule expression, however, was significantly higher among CD8+ T cells. Analysis of sorted naïve and memory T cells showed that alloreactive precursors were equally present in both populations. The CD8+ effector and terminally differentiated effector memory subsets contained the highest proportion of granzyme B/perforin after allostimulation, suggesting that these cells present a significant threat to transplanted organs. Finally, we demonstrate that virus-specific lymphocytes contribute significantly to the alloresponse in certain responder-stimulator HLA combinations, underscoring the importance of T-cell cross-reactivity in alloimmunity. These results provide a quantitative assessment of the roles of naïve and memory T-cell subsets in the normal human alloimmune response and establish a platform for measuring T-cell alloreactivity pre- and posttransplantation.

22 November 2011 in European Journal of Immunology
Verified
Journal Article
Open access
PDF file
SWSilke Wiesmayr
Silke Wiesmayr
SWSteven A. Webber
Steven A. Webber
CMCamila Macedo
Camila Macedo
IPIulia Popescu
Iulia Popescu
LSLouise Smith
Louise Smith
DMDiana M. Metes
Diana M. Metes
Post‐transplantation lymphoproliferative disorders (PTLD) are life‐threatening complications of organ transplantation caused by EBV infection and the use of chronic immunosuppression. While T‐cell impairment is known to play a critical role in the immunopathogenesis of EBV complications post‐transplantation, the role of NK cells is still under investigation. Here, we have characterized NK‐cell phenotype and function in peripheral blood from asymptomatic pediatric thoracic transplant patients, patients with PTLD, and healthy controls. Overall, asymptomatic pediatric solid organ transplant (Tx) patients presented significant expansion of the CD56brightCD16± subset and displayed effective NK‐cell function, while PTLD patients accumulated CD56dimCD16− and CD56−CD16+ NK‐cell subsets. In addition, NK cells from PTLD patients down‐regulated NKp46 and NKG2D, and significantly up‐regulated PD‐1. These phenotypic changes were associated with NK functional impairment, resembling cellular exhaustion. Disrupting PD‐1 inhibitory pathway improved IFN‐γ release, but did not enhance cytotoxicity in PTLD patients, suggesting that these defects were partially PD‐1 independent. Our results indicate the important role of NK cells during EBV surveillance post‐transplantation, with implications for the immunopathogenesis of EBV complications, and suggest that monitoring NK cells in transplant patients may hold clinical value.

15 May 2011 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
CMCamila Macedo
Camila Macedo
SWSteven A Webber
Steven A Webber
ADAlbert D. Donnenberg
Albert D. Donnenberg
IPIulia Popescu
Iulia Popescu
YHYun Hua
Yun Hua
DMDiana M. Metes
Diana M. Metes
Serial EBV load monitoring of clinically asymptomatic pediatric thoracic organ transplant patients has identified three groups of children who exhibit undetectable (16,000 copies/ml) EBV loads in peripheral blood. Chronic high EBV load patients have a 45% rate of progression to late-onset posttransplant lymphoproliferative disorders. In this article, we report that asymptomatic patients carrying EBV loads (low and high) expressed increased frequencies of EBV-specific CD8+ T cells, as compared with patients with undetectable EBV loads. Although patients with low viral load displayed EBV-specific CD8+ T cells with moderate signs of activation (CD38+/−/CD127+/−), programmed death 1 upregulation and effective IFN-γ secretion, high EBV load carriers showed significant CD38+ upregulation, features of cellular exhaustion (programmed death 1+/CD127−) accompanied by a decline in IFN-γ release. Immunopolarization of EBV-specific CD8+ T cells was skewed from the expected type 1 (IFN-γ) toward type 0 (IFN-γ/IL-5) in patients, and Tr1 (IL-10) in high load carriers. These results indicate the importance of chronic EBV load and of the levels of antigenic pressure in shaping EBV-specific memory CD8+ T cells. Concomitant phenotypic and functional EBV monitoring is critical for identifying the complex “functional” versus “exhausted” signature of EBV-specific CD8+ T cells, with implications for immunologic monitoring in the clinic.

28 July 2020 in Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
PDF file
KLKevin Louis
Kevin Louis
CMCamila Macedo
Camila Macedo
EBElodie Bailly
Elodie Bailly
LLLouis Lau
Louis Lau
BRBala Ramaswami
Bala Ramaswami
DMDiana M. Metes
Diana M. Metes
Significance Statement: Most studies investigating the mechanisms of antibody-mediated rejection, a major cause of kidney allograft failure, have focused on characterizing the role of donor-specific antibodies (DSAs), whereas the alloreactive cellular component has been less studied. On the basis of a multidimensional and concomitant profiling of circulating T follicular helper (TFH) cells and B cells, the authors identified highly coordinated responses of circulating TFH cells and activated B cells at phenotypic, functional, and transcriptional levels in patients with antibody-mediated rejection. The levels of circulating TFH cell and B cell activation were predictive of DSA pathogenicity, histologic severity, and allograft loss. This study provides novel mechanistic insights into the cellular and molecular processes underlying antibody-mediated rejection and a rationale for monitoring and therapeutic targeting of circulating TFH cell–B cell interaction during antibody-mediated rejection. Background: Although antibody-mediated rejection (ABMR) has been long recognized as a leading cause of allograft failure after kidney transplantation, the cellular and molecular processes underlying the induction of deleterious donor-specific antibody (DSA) responses remain poorly understood. Methods: Using high-dimensional flow cytometry, in vitro assays, and RNA sequencing, we concomitantly investigated the role of T follicular helper (TFH) cells and B cells during ABMR in 105 kidney transplant recipients. Results: There were 54 patients without DSAs; of those with DSAs, ABMR emerged in 20 patients, but not in 31 patients. We identified proliferating populations of circulating TFH cells and activated B cells emerging in blood of patients undergoing ABMR. Although these circulating TFH cells comprised heterogeneous phenotypes, they were dominated by activated (ICOS+PD-1+) and early memory precursor (CCR7+CD127+) subsets, and were enriched for the transcription factors IRF4 and c-Maf. These circulating TFH cells produced large amounts of IL-21 upon stimulation with donor antigen and induced B cells to differentiate into antibody-secreting cells that produced DSAs. Combined analysis of the matched circulating TFH cell and activated B cell RNA-sequencing profiles identified highly coordinated transcriptional programs in circulating TFH cells and B cells among patients with ABMR, which markedly differed from those of patients who did not develop DSAs or ABMR. The timing of expansion of the distinctive circulating TFH cells and activated B cells paralleled emergence of DSAs in blood, and their magnitude was predictive of IgG3 DSA generation, more severe allograft injury, and higher rate of allograft loss. Conclusions: Patients undergoing ABMR may benefit from monitoring and therapeutic targeting of TFH cell–B cell interactions.

1 April 1998
Verified
Journal Article
Closed access
DMDiana M. Metes
Diana M. Metes
LEL K Ernst
L K Ernst
WCW H Chambers
W H Chambers
ASA Sulica
A Sulica
RHR B Herberman
R B Herberman
PMP A Morel
P A Morel